The Steripath Gen2 ISDD product portfolio is an FDA 510(k)-cleared device platform indicated to reduce blood culture contamination. The platform integrates user-controlled negative pressure to divert and sequester the initial 1.5 to 2.0 mL of blood collected for culture.
Magnolia Medical, 888-617-3420
Pages: 1 2